SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,452,000 | -26.7% | 15,706 | -38.4% | 0.15% | -21.0% |
| Q2 2021 | $1,981,000 | +4.3% | 25,485 | 0.0% | 0.20% | -1.0% |
| Q1 2021 | $1,899,000 | -62.0% | 25,485 | -12.9% | 0.20% | -62.0% |
| Q4 2020 | $4,991,000 | +21.4% | 29,276 | 0.0% | 0.52% | +16.9% |
| Q3 2020 | $4,111,000 | -37.9% | 29,276 | -29.1% | 0.44% | -45.4% |
| Q2 2020 | $6,618,000 | +12.8% | 41,276 | -31.2% | 0.81% | +26.5% |
| Q1 2020 | $5,869,000 | -24.2% | 60,002 | 0.0% | 0.64% | -3.3% |
| Q4 2019 | $7,743,000 | +53.4% | 60,002 | -10.4% | 0.66% | +68.3% |
| Q3 2019 | $5,047,000 | -62.3% | 67,002 | -24.0% | 0.39% | -54.7% |
| Q2 2019 | $13,402,000 | +7.2% | 88,201 | -15.9% | 0.87% | +14.8% |
| Q1 2019 | $12,505,000 | +4.8% | 104,917 | -4.1% | 0.76% | +30.3% |
| Q4 2018 | $11,935,000 | -13.1% | 109,362 | +28.7% | 0.58% | +28.8% |
| Q3 2018 | $13,728,000 | +22.2% | 85,000 | 0.0% | 0.45% | +42.3% |
| Q2 2018 | $11,235,000 | – | 85,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |